全文获取类型
收费全文 | 7271篇 |
免费 | 358篇 |
国内免费 | 49篇 |
专业分类
耳鼻咽喉 | 49篇 |
儿科学 | 212篇 |
妇产科学 | 103篇 |
基础医学 | 804篇 |
口腔科学 | 149篇 |
临床医学 | 413篇 |
内科学 | 2003篇 |
皮肤病学 | 80篇 |
神经病学 | 476篇 |
特种医学 | 361篇 |
外科学 | 1334篇 |
综合类 | 36篇 |
预防医学 | 217篇 |
眼科学 | 180篇 |
药学 | 492篇 |
中国医学 | 14篇 |
肿瘤学 | 755篇 |
出版年
2023年 | 46篇 |
2022年 | 107篇 |
2021年 | 157篇 |
2020年 | 87篇 |
2019年 | 122篇 |
2018年 | 146篇 |
2017年 | 111篇 |
2016年 | 136篇 |
2015年 | 192篇 |
2014年 | 242篇 |
2013年 | 247篇 |
2012年 | 434篇 |
2011年 | 463篇 |
2010年 | 241篇 |
2009年 | 238篇 |
2008年 | 347篇 |
2007年 | 388篇 |
2006年 | 355篇 |
2005年 | 350篇 |
2004年 | 361篇 |
2003年 | 304篇 |
2002年 | 345篇 |
2001年 | 213篇 |
2000年 | 215篇 |
1999年 | 195篇 |
1998年 | 85篇 |
1997年 | 71篇 |
1996年 | 65篇 |
1995年 | 51篇 |
1994年 | 46篇 |
1993年 | 43篇 |
1992年 | 135篇 |
1991年 | 124篇 |
1990年 | 100篇 |
1989年 | 118篇 |
1988年 | 79篇 |
1987年 | 69篇 |
1986年 | 76篇 |
1985年 | 73篇 |
1984年 | 60篇 |
1983年 | 50篇 |
1982年 | 24篇 |
1979年 | 48篇 |
1978年 | 23篇 |
1977年 | 32篇 |
1976年 | 23篇 |
1974年 | 25篇 |
1971年 | 21篇 |
1969年 | 21篇 |
1967年 | 20篇 |
排序方式: 共有7678条查询结果,搜索用时 0 毫秒
211.
Fukumoto S Ishimura E Motoyama K Morioka T Kimoto E Wakikawa K Shoji S Koyama H Shoji T Emoto M Nishizawa Y Inaba M;Cilnidipine vs L-type calcium channel blockers Evaluation of Antihypertensive Renoprotective Effects in Diabetic patients 《Diabetes research and clinical practice》2012,97(1):91-98
We evaluated the antialbuminuric advantage of cilnidipine, an N/L-type calcium channel blocker (CCB), compared with L-type CCBs in diabetic patients with normoalbuminuria and microalbuminuria. The study was a multicenter, non-randomized crossover trial. Participants were 90 type 2 diabetic patients exhibiting either normo- or microalbuminuria, and undergoing CCB treatment for ≥6 months prior to study entry. The CCB at the time of entry was continued for the first 6 months (Period 1). Treatment was subsequently switched from cilnidipine to an L-type CCB, or vice versa, for the second 6-month observation period (Period 2). During Period 1, the L-type CCB group showed a significant increase of urinary albumin excretion (UAE) over time, while the cilnidipine group showed no significant elevation. During Period 2, switching of the treatment from the L-type CCB to cilnidipine resulted in significant reduction of the UAE, whereas switching from cilnidipine to the L-type CCB resulted in no significant change in the UAE. This study demonstrated that the antialbuminuric effect of Cilnidipine, but not the L-type CCBs, was sustained even in patients treated for a long time. In addition, the antialbuminuric effect can be anticipated after switching from an L-type CCB to cilnidipine, but not vice versa. 相似文献
212.
213.
Tokushige J Ueki T Sato K Fujikawa Y Shimizu I Akahane D Sumi M Ueno M Ichikawa N Kobayashi H 《[Rinshō ketsueki] The Japanese journal of clinical hematology》2012,53(5):535-539
A 56-year-old man was diagnosed with acute myeloid leukemia with myelodysplasia-related changes. Chromosomal analysis showed a complex karyotype. Complete remission could not be achieved even after several induction chemotherapy regimens, and the patient suffered from invasive pulmonary aspergillosis. He was transferred to our hospital and underwent reduced-intensity conditioning cord blood transplantation (RIC-CBT) in a non-remission state. The conditioning regimen involved fludarabine 125 mg/m2 combined with melphalan 140 mg/m2 and total body irradiation (4 Gy). GVHD prophylaxis was tacrolimus alone at relatively low concentrations (app. 5 ng/ml). On days 6 and 9 after CBT, he experienced a pre-engraftment immune reaction and hemophagocytic syndrome (HPS). We started steroid pulse therapy, but this failed to resolve the symptoms. We then administered low-dose etoposide (50 mg/m2). The symptoms gradually resolved after three administrations of etoposide and engraftment was achieved on day 35. Satisfactory hematological recovery was noted on day 300 after CBT and the patient has maintained complete remission to date. HPS is one of the most serious complications following CBT and often results in engraftment failure. This case suggests that repeated administration of etoposide may safely and effectively overcome this serious complication in some cases. 相似文献
214.
Toru Maruyama Tomoaki Kitagawa Katsushi Takeshita Keiichi Mochizuki Kozo Nakamura 《Developmental neurorehabilitation》2013,16(3-4):215-219
Since 1986, the authors have been conducting conservative treatment for idiopathic scoliosis with the combination of brace treatment and physical treatment (side shift exercise and hitch exercise). A total of 328 female patients with adolescent idiopathic scoliosis who were at least 10 years of age at the first visit, with Cobb angle of 10° at the minimum and followed until after 15 years of age or skeletal maturity were included. The average Cobb angle was 32.4° and the average age was 13.8 years at the first visit. Surgery was recommended when curvature progressed to >50°. Twenty of 328 patients (6.1%) with more severe curves to begin with (mean Cobb angle at admission of 48.5?±?9.3°) progressed to 62.2?±?8.5° and were treated with spinal fusion by the age of 16.0?±?2.6 years. The remaining 308 patients, of comparable age at inception of treatment but with a smaller original mean Cobb angle (32.4?±?11.1°), showed no significant increase in magnitude of curvature (mean 33.6?±?11.5°) by the time of discharge (18.6?±?3.1 years). The fact that curvature magnitude was maintained at <35° means that these patients will have a good prognosis for avoiding dramatic progression during adulthood. 相似文献
215.
Yoshiaki Kamikawa Tomohiro Nagayama Junichi Fujisaki Daisuke Hirabayashi Kiyotsugu Kawasaki Tomofumi Hamada Youichiro Mori Yasuko Kamikawa Hiroshi Mukai Tomoaki Sato Kazumasa Sugihara 《Oral Science International》2013,10(2):87-94
ObjectivesThe present study was undertaken to evaluate the anti-fungal activity of amphotericin B (AMPH-B), flucytosine (5-FC), fluconazole (FLCZ), miconazole (MCZ), itraconazole (ITCZ), and micafungin (MCFG) against clinically isolated Candida strains from oral candidiasis (OC) patients and to collect information useful for the treatment of OC.Subjects and methodsThe study includes 116 strains of Candida isolated from patients. The Candida species were identified by polymerase chain reaction. The minimum inhibitory concentration (MIC) of each drug against each Candida species was determined.ResultsOf the 106 participants (30 males and 76 females), 57 had OC, including 42 cases of pseudomembranous OC, 11 cases of erythematous OC, 2 cases of hypertrophic OC, and 2 cases of mixed pseudomembranous/erythematous OC. The Candida species isolated were Candida albicans (93 strains), C. glabrata (19 strains), and C. tropicalis (4 strains). AMPH-B and 5-FC had low MIC values against all species of Candida and a low incidence of resistance development. In some species of Candida, FLCZ and ITCZ showed high MICs, but MCZ had a low MIC value. AMPH-B, MCZ, and ITCZ prescribed to OC patients were effective against OC with respect to alleviation of OC symptoms.ConclusionMIC values of anti-fungal drugs against Candida strains isolated from OC patients were obtained and the 3 anti-fungal drugs given to OC patients were found to be effective against OC in spite of differences in their MIC values and in the number of resistant strains (or strains with a high MIC value). 相似文献
216.
Kazuto Hoshi Yuko Fujihara Yukiyo Asawa Satoru Nishizawa Sanshiro Kanazawa Tomoaki Sakamoto Makoto Watanabe Toru Ogasawara Hideto Saijo Yoshiyuki Mori Tsuyoshi Takato 《Oral Science International》2013,10(1):15-19
Greater progress has been made in the clinical application of cartilage regenerative medicine, compared with that of other organs. A typical example of cartilage regenerative medicine is autologous chondrocyte implantation, in which chondrocytes isolated from the patient's cartilage are cultured and injected into the cartilage defects in a liquid- or gel-form. However, the classic autologous chondrocyte implantation has been applicable to only limited diseases, including focal cartilage lesion. Therefore, we developed “implant-type” tissue-engineered cartilage that shows mechanical strength and three-dimensional shape. This type of tissue-engineered cartilage uses scaffold composed of atelocollagen hydrogel and poly-l-lactic acid porous material, which is administered with cultured autologous auricular chondrocytes. Its clinical application to nasal deformity of cleft lip and palate patients has been ongoing at present. This review presents an overview of the current situation regarding cartilage regenerative medicine, as well as introducing our research and the development of implant-type tissue-engineered cartilage for the cleft-lip nose. The discussion of the future development of regenerative medicine is also mentioned. 相似文献
217.
Shoji Ichikawa Amie K. Gray Emmanuel Bikorimana Michael J. Econs 《Calcified tissue international》2013,93(2):155-162
X-linked hypophosphatemia (XLH) is caused by mutations in the PHEX gene, which increase circulating levels of the phosphaturic hormone, fibroblast growth factor 23 (FGF23). Because XLH is a dominant disease, one mutant allele is sufficient for manifestation of the disease. However, the dosage effect of a PHEX mutation in XLH is not completely understood. To examine the effect of Phex genotypes, we compared serum biochemistries and skeletal measures between all five possible genotypes of a new murine model of XLH (Phex K496X or Phex Jrt ). Compared to sex-matched littermate controls, all Phex mutant mice had hypophosphatemia, mild hypocalcemia, and increased parathyroid hormone and alkaline phosphatase levels. Furthermore, mutant mice had markedly elevated serum Fgf23 levels due to increased Fgf23 expression and reduced cleavage of Fgf23. Although females with a homozygous Phex mutation were slightly more hypocalcemic and hypophosphatemic than heterozygous females, the two groups had comparable intact Fgf23 levels. Similarly, there was no difference in intact Fgf23 or phosphorus concentrations between hemizygous males and heterozygous females. Compared to heterozygous females, homozygous counterparts were significantly smaller and had shorter femurs with reduced bone mineral density, suggesting the existence of dosage effect in the skeletal phenotype of XLH. However, overall phenotypic trends in regards to mineral ion homeostasis were mostly unaffected by the presence of one or two mutant Phex allele(s). The lack of a gene dosage effect on circulating Fgf23 (and thus phosphorus) levels suggests that a Phex mutation may create the lower set point for extracellular phosphate concentrations. 相似文献
218.
219.
Watanabe T Urano E Miyauchi K Ichikawa R Hamatake M Misawa N Sato K Ebina H Koyanagi Y Komano J 《AIDS research and human retroviruses》2012,28(8):913-922
Rho GTPases are able to influence the replication of human immunodeficiency virus type 1 (HIV-1). However, little is known about the regulation of HIV-1 replication by guanine nucleotide dissociation inhibitors (GDIs), one of the three major regulators of the Rho GTPase activation cycle. From a T cell-based cDNA library screening, ARHGDIB/RhoGDIβ, a hematopoietic lineage-specific GDI family protein, was identified as a negative regulator of HIV-1 replication. Up-regulation of ARHGDIB attenuated the replication of HIV-1 in multiple T cell lines. The results showed that (1) a significant portion of RhoA and Rac1, but not Cdc42, exists in the GTP-bound active form under steady-state conditions, (2) ectopic ARHGDIB expression reduced the F-actin content and the active forms of both RhoA and Rac1, and (3) HIV-1 infection was attenuated by either ectopic expression of ARHGDIB or inhibition of the RhoA signal cascade at the HIV-1 Env-dependent early phase of the viral life cycle. This is in good agreement with the previous finding that RhoA and Rac1 promote HIV-1 entry by increasing the efficiency of receptor clustering and virus-cell membrane fusion. In conclusion, the ARHGDIB is a lymphoid-specific intrinsic negative regulator of HIV-1 replication that acts by simultaneously inhibiting RhoA and Rac1 functions. 相似文献
220.
Morita K Nakamura F Kamikubo Y Mizuno N Miyauchi M Yamamoto G Nannya Y Ichikawa M Kurokawa M 《International journal of hematology》2012,95(6):721-724
Lymphoma occurring in the pituitary gland is an exceedingly infrequent event. Here, we describe a case of pituitary lymphoma complicating recurrent pituitary adenoma. A 56-year-old male with a history of pituitary adenoma was diagnosed with diffuse large B-cell lymphoma (DLBCL) of the left ocular adnexa, which was successfully treated by standard chemotherapy and local radiotherapy. Eight months later, he complained of diplopia and bitemporal hemianopia. Brain magnetic resonance imaging detected a suprasellar tumor. Transsphenoidal biopsy of the mass was performed, and histopathological examination revealed DLBCL admixed with pituitary adenoma. On a review of the literature, we found that pituitary lymphoma developing within adenoma is a recurrent phenomenon. The composite tumor is likely to be characterized by suprasellar involvement and presentation of visual disturbances. Moreover, in the present case, the suprasellar tumor remained visible after autologous peripheral stem cell transplant, likely due to the residual pituitary adenoma. We therefore recommend that refractory pituitary lymphoma should be vigorously biopsied in search of possibly underlying adenoma. 相似文献